Table of Contents
Hepatitis Research and Treatment
Volume 2014, Article ID 615621, 5 pages
Clinical Study

High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B

Department of Medicine, Division of Gastroenterology, Hamad Medical Corporation (HMC), 2 South 2, P.O. Box 3050, Doha, Qatar

Received 16 June 2014; Revised 10 August 2014; Accepted 28 August 2014; Published 30 September 2014

Academic Editor: Piero Luigi Almasio

Copyright © 2014 Hamid Ullah Wani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [1 citation]

The following is the list of published articles that have cited the current article.

  • Kadri Atay, Ibrahim Hatemi, Billur Canbakan, Emine Koroglu, Emre Durcan, Berna Yurttas, Ilhami Gultepe, Sebati Ozdemir, Murat Tuncer, and Abdullah Sonsuz, “Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B,” Turkish Journal Of Gastroenterology, vol. 27, no. 3, pp. 279–283, 2016. View at Publisher · View at Google Scholar